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Abstract 
Objectives 
Juvenile Dermatomyositis is a rare, chronic autoimmune condition of childhood with known 
psychosocial implications. This study sought to establish current psychology support for 
children and young people across the United Kingdom with rheumatic conditions, with a 
specific focus on those with Juvenile Dermatomyositis. 
 
Methods 
Electronic surveys were distributed to the 15 centres that belong to the Juvenile 
Dermatomyositis Research Group in the United Kingdom, collecting responses from health 
care professionals in the fields of medicine, nursing and psychology. 
 
Results 
One hundred percent of professionals from medicine and nursing replied from all 15 
centres. Of these, 7 (47%) did not have a named psychologist as part of their rheumatology 
team, despite the majority, 13 (87%) having more than 200 paediatric rheumatology 
patients. Of the remaining centres, hospital psychology provision varied considerably. When 
rating their service, only 3 (8%) out of 40 professionals scored their service as a 5, (where 1 
is poor, 5 is excellent): there were wide discrepancies in these scores. Many challenges were 
discussed, including limited psychology provision, lack of time and difficulties of offering 
support across large geographical areas. 
 
Conclusion 
Many of the challenges discussed are applicable to other centres worldwide. Suggestions 
have been proposed which may help to improve the situation for children and young people 
with rheumatic conditions, including Juvenile Dermatomyositis. Based on these findings, we 
suggest that rheumatology teams maximise use of these data, to advocate and work 
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• Psychological support and early interventions are needed for children with rheumatic 
conditions. 
 
• Psychology support was limited in most centres surveyed and was determined by 
time and caseload. 
 
• This study highlights the importance of integrating psychology into paediatric 
rheumatology teams to benefit patients. 
 
Data availability statement : All of the data underlying this article cannot be shared publicly 
due to offering the respondents anonymity in their responses for confidentiality reasons. The 
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Juvenile Dermatomyositis (JDM) is a rare, chronic autoimmune condition of childhood 
typically diagnosed by identifiable skin rashes and symmetrical, proximal muscle weakness  
(1–3). Whilst advances with new treatment options are being made, there is still much we 
do not know about JDM, in particular its exact pathogenesis, epidemiology and long term 
outcomes (4). Whilst mortality is reported to have fallen, with rates between 2-8% in recent 
reports (5–8), there are a significant number of young people with JDM who will continue to 
have active disease into adulthood (9,10).  
It has been postulated that young people with juvenile rheumatic diseases may be more at 
risk of psychological concerns due to the characteristics of these conditions, including 
disability and chronicity  (9). A recent study demonstrated over a third of paediatric 
rheumatology patients surveyed (including those with JDM) had clinician reported anxiety 
and depression, with a worryingly equally high number of self-diagnosed symptoms (11). 
Further studies examining JDM as a distinct population have found significantly poorer 
quality of life when compared to healthy populations (12,13). More recently, young people 
with JDM described feelings of confusion, uncertainty and difference, when compared to 
their peers (3). 
Psychological services for children and young people with chronic health conditions can help 
at every step of the patient journey – at diagnosis, during treatment and beyond (14). 
According to the National Health Service (NHS) Long Term Plan there are currently over 
20,000 psychological professionals working for NHS funded services in England, which 
equates to only 1.7% of the NHS workforce (15). National standards in the UK are now in 
place acknowledging that psychological services are not simply an “adjunct” to regular 
medical care, but represent an integral component of a healthcare team for children and 
young people experiencing chronic health conditions (16,17). Of note, page 39 in ‘Facing the 
Future: Standards for Children with Ongoing Health Needs’, states that the commissioning 
and planning of paediatric services needs to:  
“ensure children have timely access to a range of mental health and psychosocial services 
that are integrated with children’s health services” (17).  
There is an ever increasing evidence base to support the clinical effectiveness of 
psychological interventions for a number of medical conditions and illnesses (18–21). 
Psychological interventions and early support are known to result in the following: 
• Better medical outcomes (e.g. by increasing levels of adherence) 
• Better psychological functioning (e.g. anxiety, low mood, distress, anger) 
• Better family functioning 
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• Reduced levels of disability and pain 
• Reduced levels of distress around procedures 
Historically however, children and young people’s mental health services have experienced 
underinvestment, but now there is a clear recognition that increased investment in this area 
is urgently needed (22). It is essential therefore, to increase our understanding of the 
psychosocial support currently available for young people with JDM at their major health 
care centres and consider future recommendations if standards are not being met.  
 
Objectives 
This study was initiated to examine psychology provision and psychosocial care for children 
with JDM across the United Kingdom (UK). Although it is well recognised that provision of 
psychosocial support is a core component of the roles of all members of a multidisciplinary 
team, this survey was particularly interested in the availability of clinical psychology. It was 
important to establish what psychology support and psychosocial provision there is in every 
centre, and as anecdotally it is known that not all centres have a paediatric rheumatology 
psychologist, to capture this comprehensively the views of paediatric rheumatology 
consultants, nurse specialists and clinical psychologists (if available) together, were sought. 
 
The following questions underpinned the study and frame the results: 
(1) What is the applied psychology provision for patients with JDM around the UK?  
(2) What role-specific factors impede or support good psychological/psychosocial care? 
(3) What are the biggest challenges when providing psychological/psychosocial care? 
(4) How do the healthcare providers in each centre rate their psychosocial provision? 
 
Setting 
The Juvenile Dermatomyositis Cohort Biomarker Study and Repository, UK and Ireland 
(JDCBS) provides the largest prospective registry and repository of linked biological and 
serological specimen collections of juvenile idiopathic inflammatory myopathies in Europe  
(23,24). Central to the success of this initiative is UK-wide collaboration and commitment to 
the study from centres belonging to the Juvenile Dermatomyositis Research Group, with 15 
of the then 17 tertiary paediatric rheumatology centres in England and Scotland being 
included at the time of this survey. 
 
Ethics 
The study complies with the 1975 Declaration of Helsinki, with full ethical approval obtained 
(ref MREC 1/3/22) ) from the Northeast York Research Committee and approved by the 
Health Research Authority, which approved the use of this survey to healthcare 
professionals. 
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The survey was tailored to each professional group: medical, nursing and psychology. This 
allowed for different questions within each section, asking about specific roles, to ensure 
questions were relevant and specific, whilst being mindful of questionnaire fatigue in busy 
healthcare professionals. For example, when asking about site data, it was felt the medical 
professionals would more easily have the answer to this question. When seeking an opinion 
about unmet psychology needs, it was felt that the nurse specialists, who may have more 
contact with patients outside of appointment times, may be more aware of these concerns. 
The surveys were divided into four sections: i) Applied Psychology Provision; ii) Role specific 
variance; iii) Challenges; iv) Rating of service. Surveys provided options for collection of both 
quantitative and qualitative data. The questions were developed in conjunction with the 
research team, who brought clinical and academic expertise. Surveys were piloted with 
three individuals from each of the three target professional groups, with no changes made. 
Full surveys are presented in Supplementary tables S1, S2 and S3. 
Contact with each centre was with the JDCBS Principal Investigator (a paediatric 
Rheumatology Consultant) and paediatric Rheumatology Clinical Nurse Specialist. First 
contact via email requested the details for the psychologist at their centre. Three centres 
were not able to identify a named psychologist who was either part of the paediatric 
Rheumatology team or was a hospital psychologist with dedicated time allocated to 
Rheumatology. Distribution of the survey was through a freely available web-based survey 
tool, Opinio. The surveys were sent via e-mail to the Rheumatology Consultant, Clinical 
Nurse Specialist and a Clinical Psychologist who works with the Rheumatology team, where 
available. Each centre therefore received three profession-specific surveys if a Clinical 
Psychologist could be identified, and if not, only two. The Consultants were known through 
the JDCBS network and the Clinical Nurse Specialists were known to the author as Lead of 
the UK Paediatric Rheumatology Specialist Nurses Group, the psychologists were identified 
through communication from either the consultant or nurse. The survey was open for 6 
weeks from the end of 2018, with two reminders sent in that time. 
 
Analysis 
Quantitative data reported, numbers of patients in each centre, scoring of their overall 
psychosocial service provision and response to binary yes/no questions. These are 
presented using descriptive statistics. Qualitative data included free text comments. These 
are summarised and presented. 
 
Results  
The results are anonymised to prevent site recognition. Anonymised quotes are used 
throughout to add explanation. Results are presented, beginning with response rate. 
 
Response rate  
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All paediatric Rheumatology consultants n = 15 (100%) replied with no missing data fields. 
All 15 (100%) nurse specialists replied with only two fields of missing data, one individual 
had not recorded their biggest challenge and one new to Rheumatology, had not scored 
their service. Of the 12 sites who were sent a survey, 11 clinical psychologists replied (92%) 
with only one centre not responding at all to the survey. In total there were three fields of 
missing data: two responders did not comment on their biggest challenges, and one did not 
rate their service. 
Site data 
Table 1 presents the numbers of patients in the centres surveyed as reported by the 
paediatric Rheumatology consultants. In 13 (87%) centres they had over 200 paediatric 
Rheumatology patients and 7 (47%) had between 10-20 JDM patients. 
(PLEASE ADD TABLE ONE HERE) 
Research questions presented in turn for each professional group 
As the questions asked of each professional group were different, the data are presented in 
four sections, each addressing one of the initial research questions, further presented by 
profession.  
 
1. Applied Psychology provision (table of quantitative data, followed by free-text 
qualitative comments from each of the professional groups) 
 
Table 2 presents the questions asked for question 1 of each professional group, and 
summary of responses.  
(PLEASE ADD TABLE TWO HERE) 
Medical professionals 
Medical professionals in 5 centres (33%) reported that they did not have a named 
psychologist as part of their Rheumatology team and one of these had no hospital 
psychology service, commenting: “We used to, but they are closed to referrals now due to 
sickness, maternity leave etc. We are reliant on local services now” (participant 7). When not 
part of the team but available in the hospital, comments included: “Very limited allocation. 
Very short staffed and last month announced that they will not be able to see any new 
referrals that are not inpatients. Totally unsatisfactory” (participant 14). Even when available 
as part of the team, there were still concerns raised: “I think most services are directed 
towards crisis management and chronic pain, I think more could be done with early 
intervention” (participant 1). 
Nurse Specialists 
Unmet needs were described as: “Body image, disease management, compliance, fatigue, 
weight gain, lack of friends, falling behind with education” (participant 13), “Overt skin 
changes & muscle weakness makes them feel different to peers and a burden on their 
family” (participant 1) and “Lots of our patients have body image issues as well as issues 
around compliance and mental health concerns” (participant 2). An additional further 
comment: “Body image, acceptance of their condition, physical impact of their 
condition….patient with self-harm” (participant 3). 
P.Livermore   May 2021 




The number and hours of psychology provision was limited for the majority of sites, one 
commented: “We have a very small amount of resource spread across all the paediatric 
specialties with no designated funding, including rheumatology so we are only able to offer a 
very brief assessment and intervention service” (participant 1). Others said: “No dedicated 
psychology time for Rheumatology” (participant 8), “No funded service – there is an informal 
agreement to accept around 12 referrals/year” (participant 10), “There is no dedicated 
service for Rheumatology in our Trust” (participant 3) and “We have a very small amount of 
resource spread across all the paediatric specialities with no designated funding so we are 
only able to offer a very brief assessment and intervention service” (participant 1). Waiting 
lists ranged from “very minimal” (participant 5) to “approximately 6 months” (participant 
10). 
 
2. Role specific variance (table of quantitative data, followed by free-text qualitative 
comments from each of the professional groups) 
 
Table 3 presents the questions asked for the second research question, examining role 
variance for each professional group, and summarises their responses. 
(PLEASE ADD TABLE THREE HERE) 
Medical professionals 
When asked ‘Do you know what percentage of your patients are seeing someone for 
psychosocial support?’ comments included: “At a guess some will have had contact but no 
regular psychology” (participant 14) and “Most of my JDM patients have seen or are seeing a 
psychologist” (participant 5). When asked ‘Do you routinely ask JDM patients or their 
families if they are seeing someone for psychosocial support?’ 9 (60%) said no, with one 
commenting: “Not routinely, only if we think there might be issues needing psychology 
input” (participant 11). Of the 6 (40%) who said yes, one commented: “I routinely ask 
adolescents (those aged 13-17) about psychological wellbeing and if this suggests difficulties 
I ask about other support via school or local doctor. I do not routinely ask the parents of 
younger children unless there is a concern” (participant 6). 
Nurse Specialists 
When asked ‘Do you and your nursing team routinely ask patients and or parents, whether 
the young person is seeing a psychologist or other similar?’ 8 (53%) said ‘no’. Three of these 
commented that they do not have the time. One reported: “During the consultation this can 
be discussed or if concerns are raised, these will be addressed” (participant 9). When asked 
‘Do you think you have enough time and/or experience and/or support to manage any 
psychosocial concerns?’ 9 (60%) said no. One commented: “No, we do not have anywhere 
near enough time to do what we need to do” (participant 2) and another said: “We do not 
have enough time” (participant 6). 
Clinical Psychologists 
Comments to the question regarding attending team meetings included “Unable to attend 
monthly psychosocial meetings as my timetable no longer allows” (participant 10). More 
specifically one of these participants commented: “10-20 minutes once per month is set 
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aside in this meeting to discuss possible referrals to psychology” (participant 8) and another 
commented that whilst they did attend meetings “the focus is patients with chronic pain” 
(participant 1). All 11 participants replied to say that newly diagnosed patients do not 
routinely see a psychologist. 
 
3. Challenges as free-text comments 
Each individual was asked what was the biggest challenge when providing psychosocial care. 
All challenges are summarised in Supplementary table S4. 
Medical professionals 
Lack of psychology provision, time and geographical boundaries were consistently discussed. 
Comments included: “Long waiting times. Big case load means they [the clinical psychology 
service] do not prioritise children with chronic diseases and are a reactive service. Regional 
politics also come into it and if they out of our city boundaries they are referred to another 
team” (participant 10), “Dedicated psychology for rheumatology patients is vital but often 
comes with unavailable and unacceptable waits” (participant 9) and “as the medical 
professional trying to secure safe, effective, and timely care for their patients, one can feel 
the frustration from arguing over health care boundaries when dealing with a child’s mental 
health” (participant 7). 
Nurse Specialists 
Lack of time and lack of psychology provision was also consistently mentioned. Others talked 
about logistical issues: “We cover a large geographical area, some are unable to travel to 
access our service” (participant 8) and: “Knowing where we access the support particularly as 
we are a regional service and patients want this care to be closer to home” (participant 3). 
Clinical Psychologists 
Capacity was also mentioned: “We have a very large catchment area since we are a 
Specialist Centre” (participant 11), “Not enough psychosocial resource in this area to meet 
need” (participant 1) and “Clinical Psychologist is very part-time and cannot easily be present 
during team clinics” (participant 7). Also, similar to the other professional groups, a recurring 
theme was lack of time: “Not having dedicated time for rheumatology limits the screening / 
pre-emptive / early intervention work that can be done” (participant 8) and “Current wait for 
assessment” (participant 2).  Another commented “the biggest challenge is not being 
integrated into the medical team” (participant 3). 
 
4. Rating of service (table of quantitative data, followed by free-text qualitative 
comments from each of the professional groups) 
Each respondent rated their psychosocial provision of their centre, these results are 
summarised in Table 4. As one psychologist did not respond at all to the survey and one 
nurse specialist and one clinical psychologist did not score their service, there is a total of 39 
replies to this question. 
(PLEASE ADD TABLE FOUR HERE) 
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The majority, 7 (47%) of medical professionals scored their service a 4, adding comments 
such as: “Our service is doing its best, but limited by the quantity of psychology provision as a 
whole” (participant 8), “Our doctors, nurses and physiotherapists provide psychosocial 
support as far as possible. When families see Clinical Psychology this is a very good service 
but the main problem is delay in accessing this” (participant 6) and “We don’t ask enough 
about mental health in our Connective Tissue Disease patients, too much focus during clinic 
is on their physical issues” (participant 11). 
Nurse Specialists 
Seven (50%) of the nurses scored their service a 3. One of the nurses commented that: “Our 
psychologist is excellent but part time. To have funding for full time hours would allow more 
accesses for families in a timely manner and another” (participant 8); “No rheumatology 
psychology support and even no [hospital] psychology support – we have campaigned for 
this over many years without success” (participant 3).  
Clinical Psychologists 
Ten out of the 11 psychologists completed this question, with 5 (50%) giving it a rating of 4 
(with a median of 4).  One commented: “We could be doing some more preventative work, 
at the time of diagnosis- education around adjustment and developmental challenges along 
the way- preparing parents for conversations about long-term conditions” (participant 5). 
Another said: “The Rheumatology team have taken on many of the psychological concepts 
and put these to good use” (participant 2).  
 
Discussion 
This research was part of a multi-phased study that firstly explored in-depth experiences of 
15 children and young people’s psychosocial needs with JDM (3) and secondly, a larger UK 
wide study which captured the views of 123 children and young people regarding their 
psychosocial needs using validated surveys (currently in preparation for publication). This 
study presents the third phase; the perspectives from the healthcare professionals. Evidence 
of need for psychological support for children who have a chronic illness and have 
experienced periods in hospital has been well described (25). Similar to other child health 
specialities (26,27), we sought to map current provision of the support available to children 
with rheumatic conditions.  
Of the clinical psychologists who commented that they do not have any dedicated funded 
Rheumatology time, this was consistent with responses from the nurses (when including the 
three sites where a named psychologist could not be identified), however, different to the 
responses of the medical professionals. A reason for this discrepancy may be that the 
psychology services provided were not formalised or funded. This concurs that 7 (47%) of 
the 15 centres surveyed do not have a named psychologist as part of the Rheumatology 
team. 
Each individual was asked to rate their hospital psychosocial provision to JDM patients as a 
whole. The scores were generally high, with for example 53% of the medical professionals 
scoring 4 or above. Of note, there were only two centres where all three health care 
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professionals scored their service the same. In both of these centres all individuals scored 
their service a 4. Both of these centres had the most psychology offered to Rheumatology, 
both with more than one individual being fully integrated into the Rheumatology team. It is 
important to note here that asking health care professionals to rate their service is a value 
judgement. For example in one centre the medical consultant had rated their service a 2, the 
nurse specialist scored it 3, and the psychologist in that centre scored it 5 (excellent). This 
shows the disparity of results from the health care professionals and the subjective, 
personal and difficult nature of allocating a score to a service. 
One of the findings throughout was lack of time to fully address psychosocial concerns, 
especially by the medical consultants and nurse specialists. This represents a fundamental 
issue with psychosocial care: there is clearly not parity of esteem given to biological and 
psychological care within consultations as advocated by the Long Term Plan (17). Another 
concern frequently discussed was the lack of early intervention to prevent psychosocial 
concerns escalating and requiring more intensive crisis management. 
The frustrations from the clinical psychologists were apparent. When answering about their 
biggest challenge: capacity, time and the limits imposed by not having funded Rheumatology 
were mentioned. There are often informal agreements to accept a certain number of 
patients per year, leading one to question what happens if you are 13th in line for a 
psychologist who is only allowed to see a quota of 12 that year?  
When asked about their biggest challenge all three professional groups talked about JDM 
being a rare disease and patients living far away from treating sites. The issues imposed by 
working within healthcare boundaries and large geographical areas, not specific to the UK, 
with many patients with JDM in the United States also having issues when accessing care  
(28). It is anticipated that many of the issues raised in this survey: lack of psychology 
support, rare disease with limited speciality knowledge, lack of time, and large geographical 
areas are applicable to other countries outside of the UK. 
Whilst research has begun into psychological support, the views of siblings and parents also 
need further study, and this paper provides a sound base from which to explore the 
experiences of psychological support from patients and their families further. 
 
Limitations 
This study has some limitations. Contacting only health care providers in the larger centres 
in the UK may make this less representative, not only to centres outside of the UK health 
system, but also, smaller UK sites who may occasionally see children and young people with 
JDM. Services change rapidly with staff leaving and joining on an ever-rolling basis, so whilst 
one centre may be struggling this month, provision of care may have improved by the next 
month. The survey also did not ask the wider team their views surrounding psychosocial 
provision, such as Occupational Therapists, Physiotherapists and School teachers. These 
remain important issues to be explored further in the future. 
 
Recommendations for practice 
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(1) More preventative work needs to be done early on in the disease trajectory, as 
supported by the comments presented throughout this paper. This can only be possible with 
more designated psychology time. 
(2) Better joined up care, especially for those families who cannot travel to the larger 
centres. As one of the medical professionals commented: “With small numbers of patients 
and wide range of ages, issues are different. More organised regional/national/virtual 
groups would be helpful” (participant 12).  
(3) Integrating psychology provision into all paediatric Rheumatology teams to benefit all 
patients (regardless of age, race, gender, disease activity) and provide more dedicated time. 
 
Conclusion 
This survey established that 7 (47%) of the 15 centres in the UK at time of the survey, did not 
have a psychologist as part of their paediatric Rheumatology multi-professional team. The 
results from this survey can help centres advocate for more support and services and use 
this data to illustrate the variations in practice. As one medical professional said: “Hopefully 
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Table 1 - Numbers of patients in centres surveyed: paediatric rheumatology patients in total 
and JDM patients 
Approximately how many patients in your whole paediatric rheumatology service? 
Number of patients Number (%) of centres 
100-200 2 (13) 
200+ 13 (87%) 
Approximately how many Juvenile Dermatomyositis patients in your centre? 
Number of patients Number (%) of centres 
0-10 4 (27%)    
10-20 7 (47%)    
20-30 2 (14%)    
30-50 1 (7%)      





Table 2. Psychology provision questions and responses 
Research Question 1.  
Clinical Psychology provision 














Do you have a named 
psychologist who provides clinical 
care to patients with rheumatic 
conditions? 
10 (67) 5 (33) - - 15 
(100) 
If no, do you have access to Trust 
wide psychology in your hospital? 
4 (80) 1 (20) - - 5 (100) 
Nurse 
Specialists 
Do you have a named 
psychologist who provides clinical 
care to patients with rheumatic 
conditions? 
7 (47) 8 (53) - - 15 
(100)  
Do you think that some of your 
patients with JDM have unmet 
10 (67) 1 (7) 4 (27) - 15 
(100) 
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psychosocial needs, and if so, 
what are these? 
Clinical 
Psychologists 
Do you have dedicated funded 
rheumatology time? 
7 (64) 4 (29) - 1 (8) 12 
(100) 
Do you have a waiting list for 
psychology input? 





Table 3. Role specific variance questions and responses 
Research Question 2. 















Do you know what percentage of 
JDM patients are currently seeing 
a psychologist or other similar 
professional, either in your 
hospital or locally? 
7 (47) 8 (53) - - 15 
(100) 
Do you ask patients (and parents) 
routinely whether they are seeing 
a psychologist or other similar in 
clinic appointments? 




Do you and your team routinely 
ask whether the young person is 
seeing a psychologist or other 
similar in appointments or on the 
phone? 
7 (47) 8 (53) - - 15 
(100) 
Do you think you have enough 
time / experience and/or support 
to manage any psychosocial 
concerns? 





Do you attend any regular 
psychosocial meetings where 
children with JDM may be 
discussed? 
7 (58) 4 (33) - 1 (8) 12 
(100) 
Do all newly diagnosed 
rheumatology patients routinely 
see a psychologist? 
 11 
(92) 
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Table 4 – Rating of psychosocial provision of centre by healthcare professionals broken 
down by discipline 










Rating 1 2 3 4 5  
Medical 
professional n (%)  
1 (7) 1 (7) 5 (33) 7 (47) 1 (7) 15 (100) 
Nurse Specialist  
n (%) 
0 (0) 2 (14) 7 (50) 4 (29) 1 (7) 14 (93) 
Clinical 
Psychologist n (%) 
1 (10) 1 (10) 2 (20) 5 (50) 1 (10) 10 (91) 
Total Number  
n (%) 




Supplementary Table S1 – Questionnaire for Medical professionals 
Question 
number 
Question asked Answer options 












3 Do you have a named psychologist who provides clinical care 
to patients with rheumatic conditions? 
Yes/No/Don’t 
know  
Free text comment 




Free text comment 
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5 Do you know what percentage of JDM patients are currently 
seeing a psychologist or other similar professional, either in 
your hospital or locally? 
Yes/No/Don’t 
know  
Free text comment 
6 Do you ask patients (and parents) routinely whether they are 
seeing a psychologist or other similar in clinic appointments? 
Yes/No/Don’t 
know  
Free text comment 
7 What is your biggest challenge when providing psychosocial 
care? 
Free text comment 
8 Please rate in your opinion the psychosocial provision for your 
rheumatology patients provided by your centre? 
1 (poor) -5 
(excellent) 
 
Supplementary Table S2 – Questionnaire for Nurse Specialists 
Question 
number 
Question asked Answer options 
1 Do you have a named psychologist who provides clinical care 
to patients with rheumatic conditions? 
Yes/No/Don’t 
know  
Free text comment 
2 Do you think that some of your patients with JDM have unmet 
psychosocial needs, and if so, what are these? 
Yes/No/Don’t 
know  
Free text comment 
3 Do you and your team routinely ask whether the young person 
is seeing a psychologist or other similar in appointments or on 
the phone? 
Yes/No  
Free text comment 
4 Do you think you have enough time / experience and/or 
support to manage any psychosocial concerns? 
Yes/No/Don’t 
know  
Free text comment 
5 What is your biggest challenge when providing psychosocial 
care? 
Free text comment 
6 Please rate in your opinion the psychosocial provision for your 
rheumatology patients provided by your centre? 




Supplementary Table S3 – Questionnaire for Clinical Psychologists 
Question 
number 
Question asked Answer options 
1 Do you have dedicated funded rheumatology time? Yes/No  
Free text comment 
2 Do you have a waiting list for psychology input? And if so, how 
long is it? 
Yes/No  
Free text comment 
3 Do you attend any regular psychosocial meetings where 
children with JDM may be discussed? 
Yes/No  
Free text comment 




Free text comment 
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5 What is your biggest challenge when providing psychosocial 
care? 
Free text comment 
6 Please rate in your opinion the psychosocial provision for your 
rheumatology patients provided by your centre? 






Supplementary Table S4 – Biggest challenges responses, from each health care professional 
Biggest challenge – medical 
professional replies  
Biggest challenge – Nurse 
specialist replies 
Biggest challenge – Clinical 
Psychologist replies 
Lack of psychology, locally 
and within Trust. Dedicated 
psychology for rheumatology 
patients is vital but often 
unavailable/ unacceptable 
wait 
Limited resources available No answer 
Time, local input Undisturbed time slots with 
the family, interactions with 
the families become problem 
solving interactions 
'Buy in' to biopsychosocial 
model. Being fully up to date 
on treatment plan.  
More could be done with 
early intervention 
Our psychology service is 
very limited, we need more 
psychology support. The 
waiting list is extremely long 
DID NOT REPLY TO SENT  
SURVEY 
Depends on individual 
patients and their 
requirements 
Admission by family or young 
person that mental health is 
an issue that needs 
addressing 
Not enough psychosocial 
resource in this area to meet 
need 
Lack of psychologist on team. 
Long waiting times. Big case 
load means they [the clinical 
psychology service] do not 
prioritise children with 
chronic diseases and are a 
reactive service. Regional 
politics also come into it and 
if they out of our city 
boundaries they are referred 
to another team 
Not enough time nor 
experience, nor access to 
resources 
No answer 
Access to psychology in 
network clinics and as the 
medical professional trying to 
secure safe, effective, and 
Wide age range for children, 
chronic nature of condition, 
not enough psych time and 
Not being integrated into the 
medical team 
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timely care for their patients, 
one can feel the frustration 
from arguing over health 
care boundaries when 
dealing with a child’s mental 
health 
long distances travelled by 
families 
Under-resourced clinical 
psychologist service which 
cannot meet demands  
Time, resource. Once they 
see psychology they get a 
good service, the delay is the 
problem 
Clinical psychologist is very 
part-time and cannot easily 
be present during team 
clinics 
Lack of psychology in the 
team or named within the 
psychology department. 
Not having a psychologist in 
JDM clinics 
Time! And we have a very 
large catchment area since 
we are a Specialist Centre 
Extremely limited in house 
psychology services 
Knowing where we access 
support particularly as we are 
a regional service and 
patients want this care to be 
closer to home. 
Logistics, I am part of a 
regional service, therefore 
providing equity of 
psychology across the service 
Time and parental 
engagement 
Time and space to see the 
young person 
Resourcing it 
Patients who live a long 
distance with poor local care 
or those that don’t engage 
with psychology input 
We offer psychology to all 
patients who need it as we 
have a dedicated clinical 
psychologist on our team 
Not having dedicated time 
for rheumatology limits the 
screening / pre-emptive / 
early intervention work 
Clinic space for psychologist Time  and consistent 
resources: we cover a large 
geographical area, some are 
unable to travel to access our 
service 
Current wait for assessment, 
- would be ideal to have the 
time to be based in clinic 
more to routinely meet 
newly diagnosed families 
Timely access Engagement with services or 
consent to referrals 
No answer 
Until recently, lack of 
psychology, now better 
No dedicated psychology 
time or specific psychologist 
identified 
No answer 
Not enough psychology time, 
waits to see our 
psychologists are getting 
longer 
No answer No answer 
 
 
